Dermata Therapeutics, Inc. - SIC # 2840 -

Ticker Exchange SIC # Website Latest Ticker
DRMA Nasdaq 2840 www.dermatarx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Dermata Therapeutics, Inc.

Dermata Therapeutics Highlights Media Recognition of Tome Skincare Following Commercial Launch - Nov 5th, 2026 6:30 am
Dermata Advances Second Tome Skincare Product Toward Expected 2027 Launch with Initiation of Acne Clinical Trial - Oct 29th, 2026 2:05 pm
BC-Most Active Stocks - Oct 15th, 2026 8:30 am
Dermata Therapeutics Announces Positive Topline Results from Cosmetic Study Evaluating Its Tome Foundational Treatment - Oct 15th, 2026 6:05 am
Papulopustular Rosacea Market Report Now Available, Covers 11 Countries Across North America, Europe, and Asia-Pacific, Profiling Galderma, Journey Medical, Dermata Therapeutics, and Dr. Reddy's Laboratories - Aug 31st, 2026 3:05 am
Dermata Therapeutics Announces Commercial Launch of Tome Foundational Treatment - Aug 25th, 2026 6:30 am
Dermata Announces Preorders Now Open for Tome Foundational Treatment Ahead of Commercial Launch - Aug 21st, 2026 6:30 am
Dermata Therapeutics Announces $3.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Aug 17th, 2026 6:30 am
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Second Quarter 2026 - Aug 11th, 2026 2:05 pm
Dermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment - Aug 5th, 2026 6:30 am
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the First Quarter 2026 - May 13th, 2026 2:05 pm
Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System - Apr 2nd, 2026 6:30 am
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025 - Mar 26th, 2026 3:15 pm
Dermata Announces Appointment of Kyra Peckaitis as Vice President, Marketing - Mar 10th, 2026 6:30 am
Dermata Opens a New Chapter with the Release of Tome Skincare - Mar 5th, 2026 7:00 am
Dermata Therapeutics Announces Closing of up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Dec 29th, 2025 2:05 pm
Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results - Nov 14th, 2025 2:05 pm